-55%

est. 2Y upside i

HealthcareSeries B

Rank

#3371

Sector

Health Care Equipment

Est. Liquidity

~4Y

Data Quality

Data: Medium

Candid Co. operates in a rapidly growing clear aligner market, projected to grow at a CAGR of ~31% to over $32B by 2030.

Last updated: March 10, 2026

Bull (10%)+194%

Candid successfully expands its B2B platform, securing major Dental Service Organization (DSO) partnerships and leveraging its proprietary AI for superior treatment outcomes, driving revenue to over $350M by 2028 and achieving a $3.5B valuation at a 10x revenue multiple, reflecting strong growth and market penetration.

Base (45%)+55%

Candid maintains its current growth trajectory in the B2B clear aligner market, securing moderate partnerships and improving its telehealth platform. Revenue reaches approximately $245M by 2028, leading to a $1.8B valuation, representing a modest but positive return.

Bear (45%)-60%

Intense competition from Align Technology and other established players, coupled with slower-than-expected adoption of its B2B model, leads to stagnant growth. Revenue remains around $160M, and a down round or acquisition at $480M wipes out a significant portion of common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

moderate

Total funding of $148M on an estimated $1.2B valuation means investors hold approximately 12.3% in liquidation preferences. In an exit at or below current valuation, common stock value would be reduced by $148M.

Dilution Risk

high

The last disclosed funding round was Series B in December 2020. It's been over five years, suggesting the company will likely need another significant funding round (Series C or D) before an exit, which will cause further dilution.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Candid Co. shares.

View all 3 open roles at Candid Co. →

Last updated: February 18, 2026

Questions to Ask at the Interview

Strategic questions based on Candid Co.'s data — designed to show you've done your homework.

  • 1

    “How is CandidPro thinking about competing directly with Align Technology's established relationships with dentists and DSOs, particularly given Invisalign's dominant market share?”

  • 2

    “With an estimated $157M in revenue, what are the key growth levers and expansion strategies for Candid to significantly increase its market penetration in the B2B clear aligner space over the next 2-3 years?”

  • 3

    “Given the Series B funding in 2019/2020 and the current market conditions, what is the company's anticipated timeline and strategy for a liquidity event for employees, and how is future dilution being managed?”

Community

Valuation Sentiment

Our model estimates -55% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.